NewsBenzingaScholar Rock Refiles Marketing Authorisation Application With EMA For Apitegromab To Treat Children And Adults With Spinal Muscular Atrophy Scholar Rock Refiles Marketing Authorisation Application With EMA For Apitegromab To Treat Children And Adults With Spinal Muscular Atrophy Benzinga 2026.10.08 12:04 (GMT+0) Open on Benzinga Other news China's Central Bank: Do a Good Job in Financial Support for the Development of the AI Industry Peter Schiff Says AI Could Rewrite the Rules of Starting a Business: ‘Don’t Look for a Job’ Hunterbrook Report: Digital Realty’s $3 Billion Georgia Data Center Hits Toxic Roadblock After White Phosphorus Found At Former Army Dump Pre-market US stocks: Memory sector broadly higher, Micron Technology (MU.O) up 2.40% AbbVie’s Dual-Target Drug Shows Phase 2 Results for Hard-to-Treat Crohn’s Disease Musk announces he will gift one SpaceX share to every child in the U.S. next year
Hunterbrook Report: Digital Realty’s $3 Billion Georgia Data Center Hits Toxic Roadblock After White Phosphorus Found At Former Army Dump
